Sanofi says dengue vaccine to be available by 2015

Sanofi has invested more than $1.7 billion in the past 20 years in developing the vaccine, which is several years ahead of potential competitors.

hidden November 04, 2014 08:15:27 IST
Sanofi says dengue vaccine to be available by 2015

Paris: Sanofi said on Monday that a late-stage clinical study showed that its dengue vaccine candidate met its main goal and was highly effective against severe cases of the disease.

The French drugmaker's Sanofi Pasteur division intends to file for registration for the vaccine in several endemic countries next year, it said in a statement.

"Subject to regulatory approval, the world's first dengue vaccine could be available in the second half of 2015," Sanofi said.

Sanofi says dengue vaccine to be available by 2015

AFP

The Phase III study involved 31,000 participants across 10 endemic countries in Asia and Latin America, Sanofi said. Every year, an estimated 500,000 people are hospitalised due to severe dengue, according to the drugmaker.

Sanofi has invested more than $1.7 billion in the past 20 years in developing the vaccine, which is several years ahead of potential competitors. The firm has built a dedicated factory near Lyon in southern France with capacity to produce 100 million doses a year.

Reuters

Updated Date:

also read

Explained: Why the IMF chief is urging China to end COVID lockdowns
World

Explained: Why the IMF chief is urging China to end COVID lockdowns

IMF managing director Kristalina Georgieva has called for a ‘recalibration’ of China's tough ‘zero-COVID’ approach, which aims to isolate every case ‘exactly because of the impact it has on both people and the economy’

12 deaths, 233 cases and counting… Why Mumbai is witnessing a measles outbreak
Health

12 deaths, 233 cases and counting… Why Mumbai is witnessing a measles outbreak

Mumbai is in the grips of a measles outbreak; the city has already recorded 12 deaths and 233 cases of the contagious viral disease. Health officials say that a disruption in the inoculation programme because of the COVID-19 pandemic as well as vaccine hesitancy has caused the surge in infections

Cannot be liable to compensate for deaths due to Covid-19 vaccines: Centre tells SC
India

Cannot be liable to compensate for deaths due to Covid-19 vaccines: Centre tells SC

The affidavit was filed in response to a plea by the parents of two girls who died due to adverse effects following Covid-19 vaccination. It said vaccines made by third parties had undergone regulatory review, and holding the state liable to provide compensation may not be legally sustainable